Sushil Patel
Chief Executive Officer at REPLIMUNE GROUP, INC.
Net worth: 2 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Philip Astley-Sparke | M | 52 | 9 years | |
| Mark Goldsmith | M | 62 | 10 years | |
| Robert Coffin | M | 59 | 9 years | |
| Sandra Horning | M | 75 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 1 years |
| Jeff Cislini | M | 49 | 4 years | |
| Dieter Weinand | M | 63 | 6 years | |
| Peg Horn | M | 61 | - | |
| Christy Oliger | F | 54 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Colin Love | M | 66 | 9 years | |
| Jack Anders | M | 47 | 6 years | |
| Andrew Schwendenman | M | 48 | 4 years | |
| Paolo Pucci | M | 63 | 4 years | |
| Flavia Borellini | M | 65 | 3 years | |
| Elizabeth Anderson | F | 66 | 9 years | |
| Hyam Levitsky | M | 66 | 6 years | |
| Thilo Schroeder | M | 42 | 6 years | |
| Barbara Weber | M | 67 | 6 years | |
| Lorence Kim | M | 49 | 2 years | |
| Joseph Slattery | M | 59 | 7 years | |
| Alexis Borisy | M | 52 | 10 years | |
| Steve Kelsey | M | 63 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 years |
| Veleka Peeples-Dyer | F | 52 | 1 years | |
| Kapil Dhingra | M | 64 | 7 years | |
| Levi Garraway | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
| Robert Skidelsky | M | 85 |
University of Warwick
| 34 years |
| Michael Walker | M | - |
University of London
| 28 years |
| Emily Hill | F | 44 | 1 years | |
| Arleen Goldenberg | F | - | - | |
| Wally Reiher | M | - | 9 years | |
| Daniel Simon | M | - | 2 years | |
| Luan M. Wilfong | F | - | - | |
| Konstantinos Xynos | M | 58 | 2 years | |
| Christopher Sarchi | M | 56 | 1 years | |
| Linnet Zia | F | - | 5 years | |
| Wei Lin | M | 63 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean Franchi | F | 57 | 4 years | |
| Pascal Soriot | M | 64 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Ian Clark | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Louis Lavigne | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Anna Seddon | F | - |
University of Warwick
| 5 years |
| John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 years |
| Kamtorn Sila-on | M | 54 |
Imperial College London
| 4 years |
| Steven Lo | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Pamela Esposito | M | 50 | 9 years | |
| Jakob Dupont | M | 58 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Vincent A. Miller | M | 62 | 5 years | |
| Robert Garnick | M | 74 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 24 years |
| Ingrid Boyes | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| William Anderson | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Alexander Hardy | M | 56 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Ryan Watts | M | 48 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Asha Das | M | 59 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| June Lee | M | 58 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Andrea Pirzkall | M | 54 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 12 years |
| Yuen Hang Chan | M | 50 |
Imperial College London
University of London
| 8 years |
| Jerry Cacia | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 years |
| Antoine Souma | M | - |
University of London
| 5 years |
| Otello Stampacchia | M | 55 | 7 years | |
| Neil Exter | M | 65 | 3 years | |
| David Nagler | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Michael Varney | M | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 years |
| Jason Rhodes | M | 54 | 7 years | |
| Martin Knight | M | 74 |
Imperial College London
| 18 years |
| Hugo Slootweg | M | 53 | 8 years | |
| Markus Gemuend | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Eric Schmidt | M | 55 | 3 years | |
| Myrtle Potter | F | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
| Arthur Levinson | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 19 years |
| Adam David Lindemann | M | 51 |
University of London
| 7 years |
| Stephen G. Juelsgaard | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 24 years |
| Tanya Lewis | F | 53 | 4 years | |
| Marianne T. Armstrong | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 3 years |
| Paul Austin Wilson | M | - |
University of Warwick
| 4 years |
| Kathrin Buvac | F | 44 |
University of London
| 4 years |
| Ching Man Li | F | 48 |
University of London
| 4 years |
| Natalie Glitzenhirn-Augustin | F | - |
University of Warwick
| 4 years |
| Yan Kit Lee | M | 53 |
University of London
| 1 years |
| Efstathios Papaefstathiou | M | 56 |
University of Warwick
| 3 years |
| Yan Wing Chan | M | 44 |
University of London
| 4 years |
| Kah Sung Chow | M | 58 |
University of Warwick
| 3 years |
| Zaida Khalida binti Shaari | F | 58 |
University of Warwick
| 3 years |
| Ching Chu Chan | F | 56 |
University of London
| 3 years |
| Tarek Rizkalla | M | - |
University of London
| 2 years |
| Jana Sivcova | F | 54 |
University of London
| 3 years |
| Ajit Kadirgamar | M | - |
University of London
| 3 years |
| Wing Kwan Lee | F | 54 |
University of London
| 1 years |
| Christopher Ware | M | - |
University of London
| 3 years |
| Damir Kaufman | M | 49 |
University of London
| 3 years |
| John Felix | M | - |
University of London
| 3 years |
| Sau Fan Leung | F | 61 |
University of London
| 3 years |
| Wai Ming Yip | M | 59 |
University of London
| 3 years |
| Yee Han Onn | M | 52 |
University of London
| 3 years |
| Pang Yen Ong | M | 62 |
University of London
| 3 years |
| Henry J. Freeman | M | - |
University of London
| 4 years |
| Wiktor Pawel Sliwinski | M | 44 |
University of London
| 4 years |
| Chun Fung Ma | M | 54 |
University of London
| 3 years |
| Nazar Amso | M | 72 |
University of London
| 3 years |
| Christopher T. Bowles | M | - |
University of London
| 3 years |
| Sau Fong Leung | F | - |
University of London
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 64 | 64.65% |
| United Kingdom | 35 | 35.35% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sushil Patel
- Personal Network
